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Diverse Substrate Recognition Mechanisms
for Rhomboids: Thrombomodulin Is Cleaved
by Mammalian Rhomboids
search through about 50% of genes in the mouse ge-
nome annotated as having a TMD and signal peptide
(approximately 1200 searched) revealed that only 12
appeared to be good candidates for Spitz-like sub-
strates (Table S1). One of these was the anticoagulant
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protein thrombomodulin, which comprises a large N-ter-
minal domain with homology to lectins and six EGF
repeats; a TMD; and a highly conserved, short cyto-Summary
plasmic domain with no recognizable motifs [9, 12].
The thrombomodulin TMD resembles the Spitz TMDThe rhomboids are a recently discovered family of
in a number of significant respects (Figure 1A), so weintramembrane proteases that are conserved across
tested whether human thrombomodulin could indeedevolution. Drosophila was the first organism in which
be cleaved by human RHBDL1 or RHBDL2 [1, 13] whenthey were characterized, where at least Rhomboids
the proteins were coexpressed in mammalian cells using1–3 activate EGF receptor signaling by releasing the
a previously described assay [1]. First, C-terminallyactive forms of EGF-like growth factors [1, 2]. Subse-
tagged thrombomodulin was assayed, and a cleavedquent work has begun to shed light on the role of these
band of expected size was detected in lysates from cellsproteases in bacteria and yeast [3–8], but nothing is
coexpressing RHBDL2, but not RHBDL1 (Figure 1B).known about the function of rhomboids in vertebrates
The experiment was repeated with N-terminally taggedbeyond evidence that the subclass of mitochondrial
thrombomodulin and the extracellular domain accumu-rhomboids is conserved [4]. Here, we report that the
lated in the medium, again in response to RHBDL2 onlyanticoagulant cell-surface protein thrombomodulin [9]
(Figure 1C). Finally, an antibody against the extracellularis the first mammalian protein to be a rhomboid sub-
domain of thrombomodulin was used to detect the accu-strate in a cell culture assay. The thrombomodulin
mulation of untagged extracellular domains in the me-transmembrane domain (TMD) is cleaved only by ver-
dium triggered by specifically RHBDL2 (Figure 1D). Astebrate RHBDL2-like rhomboids. Thrombomodulin
with other rhomboid substrates [1], thrombomodulinTMD cleavage is directed not by sequences within the
cleavage was insensitive to the broad-spectrum metal-TMD, as is the case with Spitz but by its cytoplasmic
loprotease inhibitor batimastat and was abolished whendomain, which, at least in some contexts, is necessary
the putative catalytic serine of rhomboid was mutatedand sufficient to determine cleavage by RHBDL2.
to alanine (Figures 1B–1D).These data suggest that thrombomodulin could be a
Thrombomodulin was cleaved at significantly lowerphysiological substrate for rhomboid. Moreover, the
levels than cleavage of the Drosophila substrate Spitzdiscovery of a second mode of substrate recognition
(Figure 1E). To address whether this might indicate thatby rhomboids implies mechanistic diversity in this
thrombomodulin proteolysis was a nonspecific artifactfamily of intramembrane proteases.
caused by overexpression of RHBDL2, we reduced the
levels of RHBDL2 expression over a range of 103-foldResults and Discussion
by reducing the amount of specific DNA in each trans-
fection. 100-fold reduction of input rhomboid DNA re-Identifying Mammalian Rhomboid Substrates
duced the expression of RHBDL2 to undetectable levels,Based on the hypothesis that rhomboids in Drosophila
but thrombomodulin cleavage was barely affected; andand mammals might have a conserved role in EGFR
even when input DNA was reduced 1000-fold, cleavagesignaling [1, 10], we initially investigated whether mam-
was still detectable (Figures 1E and 1F). This substoichi-malian membrane-tethered EGFR ligands were cleaved
ometric requirement resembled the cleavage of Spitzby human RHBDL1 and RHBDL2; of the seven tested,
by Drosophila Rhomboid-1 [1].none were cleaved by either human rhomboid (see Sup-
These results confirm that at least in our cell cultureplemental Data).
assay, human thrombomodulin is cleaved by RHBDL2,We next searched the mouse genome sequence for
but not RHBDL1. We tested whether RHBDL2 was spe-single transmembrane domain proteins with the widely
cific for thrombomodulin by assaying whether anotherconserved rhomboid substrate motif, previously charac-
single TMD protein in the same functional clotting com-terized in the Drosophila ligand Spitz [4, 11]. This sub-
plex as thrombomodulin, the endothelial protein C re-strate motif depends on predicted protein conformation
ceptor (EPCR) [14], was cleaved. Under the same condi-rather than primary sequence, making the search some-
tions, no EPCR cleavage was detected (Figure 1G). Wewhat subjective and difficult to automate. A manual
also assayed RHBDL2 cleavage of Pref-1 (also known
as Dlk1), a mouse protein with structural similarity to
*Correspondence: mf1@mrc-lmb.cam.ac.uk thrombomodulin [15], which was in our list of 12 candi-
1Present address: Paediatric Research Centre, Tampere University date substrates; again, no cleavage was detected (not
Hospital, Building FM3, Tampere, FIN-33014, Finland.
shown). Moreover, the TMDs of the other 10 proteins2 Present address: Center for Neurologic Diseases, Harvard Medical
that we identified as potential rhomboid substrates wereSchool and Brigham and Women’s Hospital, 77 Avenue Louis
Pasteur, 750 HIM, Boston, Massachusetts 02115. also uncleaved by mouse RHBDL2 when expressed as
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Figure 1. Human Thrombomodulin Is Cleaved by RHBDL2
(A) Alignment of the human thrombomodulin and Drosophila Spitz
transmembrane domains. The conformationally similar residues are
highlighted: small, relatively hydrophilic, and -branched residues
in the top three positions (underlined) followed by a potentially helix-
destabilizing pair of residues (bold). Figure 2. Specificity of Thrombomodulin Cleavage
(B–E) Western blots of lysates (lys) or media (med) from COS or
(A) A variety of rhomboids were cotransfected with GFP-tagged
NIH3T3 cells transfected with combinations of human thrombomo-
human thrombomodulin (left two panels) or mouse thrombomodulin
dulin and rhomboids. (B) C-terminally V5-tagged thrombomodulin
(right), and the thrombomodulin released into the medium was de-
was coexpressed in NIH3T3 cells with human RHBDL1 (R1), 5 or
tected by Western blot. Left: human thrombomodulin was cleaved
100 ng of RHBDL2 (R2), or 100 ng of an active site mutant of RHBDL2
in NIH3T3 cells by human (hR2) and mouse RHBDL2 (mR2), but not
(R2-SA); 250 ng of thrombomodulin-V5 DNA was used in each lane
by Drosophila Rhomboid-1 (dR1) or AarA from Providencia stuartii.
except that marked by a white asterisk, in which 750 ng was used.
Middle: human thrombomodulin was also cleaved in COS cells by
Full-length thrombomodulin is indicated (arrowhead); the tagged
the apparent RHBDL2 ortholog from the zebrafish Danio rerio (zR2).
cleaved form runs adjacent to the 17 kDa marker. (C) N-terminally
Right: mouse thrombomodulin was cleaved in NIH3T3 cells only by
GFP-tagged thrombomodulin was coexpressed in NIH3T3 cells with
mouse RHBDL2; this is most apparent in the lysate, where the
RHBDL1 (R1), 5 or 100 ng of RHBDL2 (R2), or 100 ng of an active
cleaved but not-yet-secreted band is indicated by an arrowhead.
site mutant of RHBDL2 (R2-SA). The metalloprotease inhibitor bati-
Note that there is a background band in every lane of the medium
mastat (BB-94; 20 M) was included in all but the first lane to inhibit
blot; the specific cleaved product is slightly smaller.
background shedding of cell surface proteins. (D) Thrombomodulin
(B–E) Immunofluorescent staining of COS cells transfected with HA-
was similarly coexpressed in NIH3T3 cells with rhomboids, and anti-
tagged mouse rhomboids and GFP-tagged mouse thrombomodulin
thrombomodulin extracellular domain (Santa Cruz) was used to con-
is shown. In (B), RHBDL1; in (C), RHBDL2; in (D), RHBDL3; and in
firm RHBDL2-specific shedding; this blot was done under nonreduc-
(E), thrombomodulin.
ing conditions. In this and subsequent experiments, 20 M batimas-
tat was included in all assays unless otherwise noted. (E) Titration
of RHBDL2 activity against thrombomodulin (left lanes) and Spitz proteins that are uncleaved by rhomboids [3, 11], these
(right lanes) in COS cells. In each case, decreasing levels of RHBDL2 results further indicate the specificity of TMD cleavage
DNA was included in the transfection (shown in ng; normally 250
by rhomboids, suggesting the possibility that thrombo-ng per transfection is used). The GFP-tagged shed products were
modulin cleavage might have physiological significance.detected in medium; thrombomodulin and Spitz indicated by black
and white arrowheads, respectively. Expression of the substrate
was monitored in cell lysates (lys). Only RHBDL2-like Rhomboids Cleave
(F) Under the same conditions, the expression of HA-tagged Thrombomodulin
RHBDL2 was followed; unlike the cleavage of substrates, RHBDL2 The ability of RHBDL2, but not RHBDL1, to cleave throm-
expression decreased proportionally to input DNA.
bomodulin led us to examine whether other rhomboid(G) N-terminally GFP-tagged endothelial protein C receptor (EPCR)
proteases could also cleave thrombomodulin, by anal-was not shed in NIH3T3 cells in response to RHBDL2.
ogy to the cleavage of Drosophila Spitz by many rhom-
boids. Human thrombomodulin was cleaved by human
and mouse RHBDL2 and the zebrafish ortholog ofpart of chimeric molecules analagous to the “TM” chi-
mera in Figure 4 (not shown). This suggests that our RHBDL2; however, it was not cleaved by Drosophila
Rhomboid-1 or the bacterial rhomboid AarA, both ofability to predict substrate TMDs from sequence alone
is limited. More positively, taken with the other TMD which cleave Spitz [1, 3] (Figure 2A). We also tested the
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cleavage of mouse thrombomodulin by all of the three
nonmitochondrial mouse rhomboids identifiable in the
mouse genome; only RHBDL2 showed activity (Figure
2A). In all cases where cleavage occurred, it was depen-
dent on the presence of the catalytic serine of RHBDL-2:
activity was abolished when the serine was mutated to
alanine (not all shown). Note that the specificity implied
by our conclusion that only RHBDL2 cleaves thrombo-
modulin must be qualified by the fact that no substrate
has yet been found for RHBDL1 and RHBDL3 (also
known as ventrhoid [16]) (our unpublished data). Both
contain all the conserved catalytic residues, so we pre-
sume they are active proteases, but it remains possible
that they lack proteolytic activity.
A potential explanation for the inability of RHBDL1
and RHBDL3 to cleave thrombomodulin would be that
the enzymes and substrates are segregated from each
other within the cell. To address this, we examined the
localization of HA-tagged mouse RHBDL1, 2, and 3 us-
ing protocols previously described [10]. All three were
localized in the secretory pathway, specifically the Golgi
apparatus and the plasma membrane. Although there
was some variability, RHBDL1 was quite restricted to
the Golgi apparatus (Figure 2B, arrow) and only weakly
detected at the plasma membrane; conversely, RHBDL2
was predominantly at the plasma membrane (Figure 2C);
Figure 3. Thrombomodulin Is Cleaved in Its TMDRHBDL3 was seen weakly in the Golgi apparatus (Figure
(A) The RHBDL2 cleavage site of mouse thrombomodulin was2D, arrow) but also at the plasma membrane and in dots
mapped by comparing in cell lysates the cleaved product (lowerthat appear to be endosomes. GFP-tagged thrombomo-
band in lanes marked “cl.”) with truncations of thrombomodulin thatdulin was also located in the secretory pathway–visible
precisely mimic cleavage at the indicated amino acid residues. The
in the ER, the Golgi apparatus, and the plasma mem- cleaved product was perceptibly smaller than the 528 truncation
brane (Figure 2E). These data indicate that differential but larger than the 508.
(B) A similar analysis was performed with thrombomodulin with acompartmentalization cannot account for the specificity
large N-terminal deletion. Coordinates correspond to the same num-of RHBDL2 for thrombomodulin.
bering system as in (A).
(C) A diagram of the position of the coordinates used in the mapping.
(D) A series of TMD (top group) and juxtamembrane (bottom group)RHBDL2 Cleaves Thrombomodulin near
mutants of human thrombomodulin were assayed for their ability to
the Top of Its TMD be cleaved by RHBDL2. Mutations are shown in bold; none abro-
Rhomboids are unique among proteases responsible gated cleavage.
for shedding eukaryotic extracellular signaling domains
in that instead of cleaving in the extracellular juxtamem-
brane region, they are intramembrane proteases that thrombomodulin cleavage is most likely at residues 518,
519, or 520, corresponding to the top region of the TMDcut within the TMD [1]. There was insufficient cleaved
extracellular domain of thrombomodulin in medium to (Figure 3C). Importantly, this result strongly supports
the conclusion that thrombomodulin is a direct substrateallow a direct biochemical determination of the RHBDL2
cleavage site. We therefore mapped it by comparing the of RHBDL2, as rhomboids are the only proteases known
to cleave within TMDs near the luminal/extracellularsize of the cleaved, GFP-tagged N-terminal fragment
with identically tagged artificial truncations of the pro- side.
Spitz-like rhomboid substrates depend on helix-tein. In the first series of experiments, the cleaved frag-
ment of full-length mouse thrombomodulin in cell ex- destabilizing residues in the top part of their TMDs and
require reasonably hydrophilic residues in the same re-tracts was compared with C-terminal truncations that
contained the whole N-terminal region. The fragment gion [11]. Based on this requirement and our previous
ability to abrogate cleavage with TMD mutations, wewas larger than truncations at residue 508 but smaller
than truncations at residue 528 (Figure 3A). This located made an extensive set of mutations in the TMD and the
juxtamembrane region of thrombomodulin (Figure 3D),the approximate site of cleavage to between residues
510 and 525 (note that we predict the TMD to run from but none of these changes prevented or substantially
reduced cleavage by RHBDL2 (not shown). This inabilityresidues 517–539).
We performed a second set of experiments in which to block RHBDL2 cleavage suggests that it might occur
by a distinct mechanism to the cleavage of Spitz. Thismost of the thrombomodulin N terminus had been re-
moved, resulting in smaller protein fragments and more would be consistent with our observation that bacterial
and Drosophila rhomboids cannot cleave thrombomo-precise size comparisons. This series gave results con-
sistent with the first series, and the cleaved fragment dulin, whereas they cleave Spitz efficiently. There is al-
ready evidence that Spitz-type recognition is not thewas larger than 514 but indistinguishable from the 519
truncation (Figure 3B). We conclude that the site of only mechanism that exists: the Drosophila EGFR ligand
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Figure 4. The Cytoplasmic Domain of Throm-
bomodulin Directs RHBDL2 Cleavage
A panel of GFP-tagged potential RHBDL2
substrates was assayed by Western blot by
coexpressing them in COS cells with human
RHBDL2 (h2) or Drosophila Rhomboid-1 (d1);
in each set of four lanes, the left-hand lane
is a shedding control without batimastat,
while all other lanes show assays performed
in the presence of 20 M batimastat. The
bands corresponding to RHBDL2 shedding
are indicated by asterisks. The substrate is
indicated diagrammatically above each set of
four lanes; see Experimental Procedures for
coordinates of chimeras. Color code: green,
GFP; yellow, Spitz; red, thrombomodulin
(which, when full-length, includes lectin (L)
and EGF (E) motifs); dark blue, TGF; light
blue, Drosophila Delta.
Gurken is efficiently cleaved by rhomboids but does not into an enzyme that could cleave thrombomodulin, al-
though the chimeric rhomboid retained activity againstappear to conform to the structural constraints identified
in Spitz [2, 11]. Spitz (Figure 5B). These results support the idea that
the cytoplasmic domains of thrombomodulin and
RHBDL2 are involved in the recognition of the substrate,The Cytoplasmic Domain of Thrombomodulin
although they also suggest that other parts of RHBDL2Directs Its Cleavage by RHBDL2
participate.Since the TMD mutations did not prevent thrombomo-
dulin cleavage, a series of domain swaps and deletions
were used to map the determinants that allow it to be Function of Thrombomodulin
cleaved by RHBDL2 (Figure 4). Removal of either the The role of thrombomodulin in the protein C anticoagula-
N-terminal portion (JC chimera) or the whole (TMC tion pathway is well established [reviewed in 9, 12]. It
chimera) of the extracellular domain did not abrogate is expressed on endothelial cells that line the blood
cleavage. However, a chimera comprising an extracellu- vessels where it forms a complex with the clotting factor
lar tag, the thrombomodulin TMD, and a cytoplasmic thrombin, inhibiting thrombin’s interaction with fibrino-
domain from TGF (TM chimera), was not cleaved. This gen. At the same time, the thrombin-thrombomodulin
implied that unlike Spitz, the TMD of thrombomodulin
is not sufficient to confer cleavage/recognition by
RHBDL2. Furthermore, it demonstrated that again, un-
like Spitz, the cytoplasmic C terminus of the protein
is necessary. To examine the role of the cytoplasmic
domain of thrombomodulin further, we tested whether
it was also sufficient for RHBDL2 cleavage. Strikingly,
the cytoplasmic domain of thrombomodulin was suffi-
cient to transform the TMD of either Drosophila Delta
or human TGF—both type 1 transmembrane proteins—
into RHBDL2 substrates (Figure 4, chimeras CD, CT).
These experiments imply that the cytoplasmic domain
Figure 5. The N-Terminal Cytoplasmic Domain of RHBDL2 Partici-of thrombomodulin is both necessary and sufficient for
pates in Thrombomodulin Cleavagethe cleavage of the thrombomodulin TMD. It is also suffi-
(A) Thrombomodulin shedding into the medium (med) by mousecient to direct cleavage by RHBDL2 of at least two other
RHBDL2 (m2) is reduced when its cytoplasmic domain is deletedTMDs that are not otherwise substrates.
(N); the lysate (lys) panel shows that thrombomodulin was ex-One interpretation of these data is that the cyto-
pressed at equivalent levels. This experiment was done in the pres-
plasmic domains of RHBDL2 and thrombomodulin par- ence of 20 M batimastat.
ticipate in the enzyme/substrate recognition mecha- (B) Left: Drosophila Rhomboid-1 (d1), human RHBDL2 (h2), and a
chimera comprising Drosophila Rhomboid-1 with its N terminusnism. We have begun to investigate this by deleting the
replaced by the equivalent domain of human RHBDL2 (dh) all shedN terminus of RHBDL2. This significantly reduced its
Spitz. All assays done in presence of 20 M batimastat. Right: inactivity against thrombomodulin (Figure 5A), suggesting
contrast, thrombomodulin is shed only by RHBDL2 (arrowhead),a function for the RHBDL2 cytoplasmic domain. How-
but not by Drosophila Rhomboid-1 or the chimera. In this case,
ever, substituting the N-terminal cytoplasmic domain of batimastat (BB-94) was added to the assays shown in all but the
Drosophila Rhomboid-1 with the equivalent domain of left-most lane. Coordinates of all constructs are given in the Experi-
mental Procedures.RHBDL2 was not sufficient to transform Rhomboid-1
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